发明名称 USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS
摘要 Provided herein are methods for alleviating symptoms in a subject having a neurodegenerative disorder, comprising administering to the subject an effective amount of an isolated binding molecule which specifically binds to semaphorin-4D (SEMA4D) or to its Plexin-B1 or Plexin-B2 receptors.
申请公布号 US2015353641(A1) 申请公布日期 2015.12.10
申请号 US201514753882 申请日期 2015.06.29
申请人 VACCINEX, INC. 发明人 Smith Ernest S.;Zauderer Maurice;Bowers William J.;Jonason Alan
分类号 C07K16/28;A61K45/06;A61K39/395 主分类号 C07K16/28
代理机构 代理人
主权项 1. A method of alleviating symptoms in a subject having, or suspected of having, Huntington's disease (HD), comprising administering to the subject an effective amount of an isolated binding molecule that specifically binds to semaphorin-4D (SEMA4D).
地址 Rochester NY US